HomeNewsBusinessStocksStocks in news: Sun Pharma, Aurobindo, Sobha, Tata Comm
Trending Topics

Stocks in news: Sun Pharma, Aurobindo, Sobha, Tata Comm

ICICI Bank | SBI | Axis Bank | Jaiprakash Power Ventures | Sun Pharma | Indiabulls Housing Finance | Aditya Birla Nuvo | Adani Enterprises | Phoenix Mills | Reliance Communications | Bharti Airtel | Aurobindo Pharma | Sobha | Siemens India and Tata Communications are stocks, which are in the news today.

October 07, 2015 / 10:26 IST
Story continues below Advertisement

Here are stocks that are in news today:

Temasek Holdings unit Singapore Tech Telemedia in race to buy Tata Communications’ data centre business-Deal value estimated at USD 700 million (Rs 4,421 crore): ToI

Story continues below Advertisement

Tata-SIA & CAPA study on aviation: Mukund Rajan, Tata Sons says-Indian aviation could add USD 250 billion to value add by 2025Alert: Value add currently stands at USD 10 billion-Mumbai airport will run into significant capacity issues in 3 years-Sales tax on aviation turbine fuel (ATF) biggest drag on competitiveness-5/20 rule does not exist anywhere else in the world-5/20 rule is not serving the interests of India-Argument of putting any curbs on new airlines flying abroad is meaningless-70 percent of traffic to & from India being carried by foreign airlines-Indian carriers not being allowed to fly abroad hurts competitiveness-Enhancing capabilities of regulator crucial for the sector-Government needs to focus on bringing down costs of aviation sector-Market needs clarity on India’s long-term goals-Hope draft aviation policy has a long-term vision for aviation sectorVistara CEO Phee Teik Yeoh says-Jet fuel prices in India highest in the world-Sales tax on ATF must be cut to bring down cost of business-Landing charges & passenger fee in India among the highest-Royalty on ground handling prohibitively high-Need for transparency in approval process; simplify route dispersal norms-Government can incentivise companies to fly to non viable routes through air services fund

Aurobindo Pharma: Sources-Company likely to launch QIP issue today, looking to raise USD 250-300 million-Total equity dilution around 3-4 percent on post basis-Promoter stake in company likely to stay above 50 percent-Company has an enabling resolution to raise up to USD 350 million